Second, during the different stages of cognitive impairment, other factors such as inflammation, amyloid, tau may attenuate the effect the traditional cardiovascular risk factors such as hypertension, hyperlipidemia, and diabetes (31, 32). This evidence concerns the gene MAPT and Hypertension.